Search results
Results from the WOW.Com Content Network
Shares of Viatris (NASDAQ: VTRS) were jumping 6% higher as of 11:18 a.m. ET on Thursday after rising as much as 12.4% earlier in the day. The solid gain came after the global healthcare company ...
SCHD: Known for its mix of high-quality, high-yield U.S. stocks, SCHD has a solid track record of dividend growth, offering income and potential for capital appreciation.
See the 10 stocks » *Stock Advisor returns as of September 30, 2024. Mark Roussin, CPA has positions in Schwab U.S. Dividend Equity ETF. The Motley Fool has no position in any of the stocks ...
Stock Requirements for SCHD to join its 103 stock listing roster include: Minimum of 10 consecutive years of dividend payments. $2 million minimum 3-month trading volume average.
In April 2023, Viatris was recognized by LinkedIn as one of the 25 best companies to work for in India, [21] and one of the 25 best companies offering career development in Ireland. [22] In May 2023, USA Today included Viatris in its list of 400 US companies that have reduced their greenhouse gas emissions intensity from 2019 to 2021. [23]
Until recently, Viatris (NASDAQ:VTRS) was considered a value play among drug stocks. But after its recent earnings report, and announced sale of a key asset? ... Falling by about 23% right after ...
The stock of Viatris (NAS:VTRS, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.
Viatris also reaffirmed its full-revenue revenue forecast to the range of $15.5 billion to $16 billion, compared to analysts' estimates of $15.60 billion. Excluding items, the company reported a ...